deltatrials
Unknown OBSERVATIONAL NCT04557137

Fatigue and Quality of Life in Patients With Neuroendocrine Neoplasia

Sponsor: University of Aarhus

Conditions Neuroendocrine Tumors (NET) Health Related Qualito of Life (HRQoL)
Interventions Somatostatin analog
Updated 5 times since 2020 Last updated: Sep 14, 2020 Started: Sep 1, 2020 Primary completion: Sep 1, 2022 Completion: Jan 1, 2023
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT04557137, this observational or N/A phase trial focuses on Neuroendocrine Tumors (NET) Health Related Qualito of Life (HRQoL) and remains ongoing. Sponsored by University of Aarhus, it has been updated 5 times since 2020, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Status Flow

~Oct 2020 – ~Jan 2021 · 3 months · monthly snapshot~Jan 2021 – ~Feb 2023 · 25 months · monthly snapshotRecruiting~Feb 2023 – ~Jul 2024 · 17 months · monthly snapshotUnknown Status~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – present · 22 months · monthly snapshotUnknown

Change History

5 versions recorded

  1. Sep 2024 — Present [monthly]

    Unknown

  2. Jul 2024 — Sep 2024 [monthly]

    Unknown

    Status: Unknown Status → Unknown

  3. Feb 2023 — Jul 2024 [monthly]

    Unknown Status

    Status: Recruiting → Unknown Status

  4. Jan 2021 — Feb 2023 [monthly]

    Recruiting

  5. Oct 2020 — Jan 2021 [monthly]

    Recruiting

    First recorded

Sep 2020

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • University of Aarhus
Data source: University of Aarhus

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations